Injectable codeine is accessible for subcutaneous or intramuscular injection only; intravenous injection is contraindicated, as this can result in nonimmune mast-cell degranulation and resulting anaphylactoid response. Codeine suppositories are promoted in some international locations. In Eire, new regulations arrived into effect on one August 2010[ninety] relating to codeine, on account https://codeingil.com/